Advertisement

Search Results for "Metoprolol Succinate Bio Study Article"

16:32 EDT 21st May 2013 | BioPortfolio

Original Source: Efficacy and Safety of Metoprolol Succinate Prolonged-Release Tablet in Patients With Mild to Moderate Hypertension

This is an open-label, non-comparative, multi-centre clinical study to evaluate the Efficacy and safety of Metoprolol Succinate prolonged-release tablet (Betaloc Zok) in patients with mild to moderate essential hypertension.

Matching Channels

Pediculosis - louse (lice) infestation

   To view our most recent article on Lice Infestation please go to: http://www.bioportfolio.com/news/article/987568/Pediculosis-Louse-Lice-Infestation.html 

SERAPHIN study

SERAPHIN - STUDY WITH ENDOTHELIN RECEPTOR ANTAGONIST IN PULMONARY ARTERIAL HYPERTENSION TO IMPROVE CLINICAL OUTCOME. SERAPHIN (Study with an Endothelin Rece...

Hepatology

Hepatology is the study of liver, gallbladder, biliary tree, and pancreas, and diseases associated with them. This includes viral hepatitis, alcohol damage, cirrhosis and cancer. As modern lifestyle...

Pediculosis - louse (lice) treatment

   To view our most recent articles on Lice Treatment please go to: http://www.bioportfolio.com/news/article/987636/Pediculosis-Louse-Lice-Treatment.html    

Pediculosis - louse (lice) diagnosis

   To view our most recent articals on Lice Diagnosis please view: http://www.bioportfolio.com/news/article/987588/Pediculosis-Louse-Lice-Diagnosis.html

Matching News

Dr. Reddy’s Announces the Launch of Metoprolol Succinate ER (Extended-Release) Tablets

Dr. Reddy’s Laboratories (NYSE: RDY) announced today that is has launched Metoprolol Succinate ER (Extended-Release) Tablets (25 mg, 50 mg, 100 mg & 200 mg), a bioequivalent...

Dr. Reddy's unveils high blood pressure tablets in US

Dr. Reddy's Laboratories, an integrated global pharmaceutical company, has introduced Metoprolol Succinate extended-release (ER) tablets of 25mg, 50mg, 100mg and 200mg strengths in the US.

Beta-blockers not equal in LQTS, metoprolol appears least effective

NEW YORK (Reuters Health) - Propranolol and nadolol are nearly four times better than metoprolol at preventing breakthrough cardiac events in symptomatic patients with long QT syndrome (LQTS), a r...

Atenolol, Metoprolol Similar in CV Event Prevention

A study comparing atenolol and metoprolol tartrate for hypertension treatment shows similar effects on incidence of stroke, myocardial infarction, and heart failure. Medscape Medical News

Atenolol, metoprolol equally cardioprotective in hypertensive new users: study

NEW YORK (Reuters Health) - Atenolol and metoprolol tartrate work equally well in preventing a first cardiovascular event in hypertensive patients, according to an observational study.

AAPS PharmSciTech: Preparation and Evaluation of Sustained-Release Matrix Tablets Based on Metoprolol and an Acrylic Carrier Using Injection Moulding

Type: Original PaperSustained-release matrix tablets based on Eudragit RL and RS were manufactured by injection moulding. The influence of process temperature; matrix composition; drug load, plasticiz...

Carvedilol Beats Metoprolol in Some HF Patients (CME/CE)

(MedPage Today) -- Patients with mild heart failure and an implanted CRT-D device to regulate heart rhythm appear to do better with the beta-blocker carvedilol than with metoprolol, a subanalysis of M...

Succinate is an inflammatory signal that induces IL-1β through HIF-1α

Macrophages activated by the Gram-negative bacterial product lipopolysaccharide switch their core metabolism from oxidative phosphorylation to glycolysis. Here we show that inhibition of glycolysis wi...

Matching PubMed Articles

Tablet splitting: Product quality assessment of metoprolol succinate extended release tablets.

Metoprolol succinate extended release tablets comprise a multiple unit system containing metoprolol succinate in a multitude of controlled release pellets. Each pellet acts as a separate drug delivery...

Pulsatile multiparticulate drug delivery system for metoprolol succinate.

Cardiovascular diseases and their treatment pose a great challenge. Many instances of cardiovascular disease occur in the early morning hours. Hence, the objective of this study was to develop a time-...

Response to metoprolol succinate sustained-release tablets in correlation to pulse pressure, serum vascular endothelial growth factor and C-reactive protein in elderly hypertensive patients with chronic heart failure.

OBJECTIVE: To investigate the effect of metoprolol succinate sustained-release tablets on cardiac function, serum vascular endothelial growh factor (VEGF) and C-reactive protein (CRP) in elderly hyper...

Effect of fixed dose combinations of metoprolol and amlodipine in essential hypertension: MARS - A randomized controlled trial.

Abstract Aim. To compare two strengths of a fixed drug combination (FDC) containing metoprolol XL and amlodipine (metoprolol/amlodipine 50/5; and metoprolol/amlodipine 25/2.5) with its components in...

Differential effects of metoprolol and atenolol to neuropeptide Y blockade in coronary artery disease.

Abstract Objective. To explore possible differential effects between metoprolol and atenolol in patients with coronary artery disease. Design. The study was randomized, double blind, two-way crossov...

Search Whole site using Google

Loading
Search BioPortfolio:
Advertisement
Advertisement
Advertisement Advertisement